BME100683
Anti-CD19(tafasitamab biosimilar) mAb

Größe
£181.00
- SKU:
- BME100683
- Zusätzliche Namen:
- MOR208; XmAb5574; XmAb®5574; MOR-00208; MOR-208; XENP-5574; XMP-5574; XmAb-5574; Xmab-CD19; Xmab5574; tafasitamab-cxix
- Lagerbedingungen:
- Store at -20[o]C to -80[o]C for 12 months in lyophilized form. After reconstitution; if not intended for use within a month; aliquot and store at -80[o]C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.
- Hersteller:
- DIMA Biotechnology Ltd
- Reaktivitäten:
- Human
- Formulierung:
- Lyophilized from sterile PBS; pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
- Target:
- CD19
- Weitere Details:
- Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Versandbedingungen:
- Ambient
